TrialFinder  /  Landscape Report ANXIETY  ·  2026-10-26 Revasser  /  revasserkernel.com
Landscape Report TrialFinder
SOURCE  ClinicalTrials.gov API v2
GENERATED  2026-10-26
VERSION  v1
SAMPLE  100 of 7453 studies

anxiety

The anxiety clinical trial landscape includes 7453 actively recruiting trials. Semantic expansion identified 6233 additional trials beyond exact-match search, representing a 510.9% discovery lift across related conditions and therapeutic approaches.

Recruiting
7453
active trials
Expansion Lift
+510.9%
6233 additional trials
Top Sponsor
VA Office of Research and Development
4 trials
Dominant Phase
NA
58 of 101 sampled
Pipeline Overview
Phase Distribution
NA
58
Phase 1
5
Phase 2
5
Phase 3
4
Phase 4
3
Other
26
Therapeutic Modalities
BEHAVIORAL
50
OTHER
46
DRUG
36
DEVICE
26
PROCEDURE
6
DIETARY_SUPPLEMENT
3
RADIATION
1
BIOLOGICAL
1
Recruiting vs. Completed (2yr)
Recruiting
7453
Completed
5282
Competitive Landscape
Sponsor Classification
16%
76%
4%
4%
FED (4)
OTHER (19)
INDUSTRY (1)
OTHER_GOV (1)
Top Sponsors
SponsorTrialsClass
VA Office of Research and Development4FED
The University of Texas Health Science Center, Houston3OTHER
Emory University2OTHER
Dr. Inge Winter2OTHER
Drexel University2OTHER
University Hospital, Montpellier2OTHER
Assistance Publique - Hôpitaux de Paris2OTHER
First Affiliated Hospital of Fujian Medical University1OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1OTHER
MD Stem Cells1INDUSTRY
Henan Cancer Hospital1OTHER_GOV
University of South Florida1OTHER
Mayo Clinic1OTHER
University Hospital, Lille1OTHER
Ardahan University1OTHER
Geographic Distribution
Top U.S. States by Trial Density
StateTrialsTop City
California8San Diego
Texas7Houston
New York5New York
Pennsylvania5Philadelphia
Massachusetts5Boston
Florida3Coconut Creek
Georgia3Atlanta
Alabama3Birmingham
Oregon3Portland
Minnesota2Rochester
Maryland2Baltimore
South Carolina2Charleston
Louisiana2New Orleans
Tennessee2Nashville
Wisconsin2Milwaukee
Colorado1Aurora
Utah1Orem
North Carolina1Salisbury
Connecticut1New Haven
Ohio1Cleveland
Expansion Intelligence
+510.9%
Discovery lift — trials found by semantic expansion that exact-match search misses entirely. This is the gap competitors don't see.
4
Exact
1
Parent
6
Related
5
Comorbid
6
Therapeutic
Top Expansion Terms
  • psychiatric disorder Parent
  • panic disorder Related
  • agoraphobia Related
  • specific phobia Related
  • separation anxiety Related
  • selective mutism Related
  • social phobia Related
  • depression Comorbid
  • insomnia Comorbid
  • irritable bowel syndrome Comorbid

These terms are curated from clinical literature — not generated by a language model. Each captures trials that use variant nomenclature for the same underlying condition or therapeutic area.

Key Findings
What This Landscape Means for anxiety
high
Standard searches miss 511% of relevant trials for anxiety — semantic expansion across related conditions and therapeutic approaches is essential for complete landscape visibility.
6233 additional trials found via expansion vs 1220 exact matches
high
4 Phase 3 trials indicate a maturing pipeline with near-term approval potential.
Phase 3 represents 4% of sampled trials
Next Steps
Take Action on This Intelligence
//
Stay Current
Get alerted when new trials open for anxiety and related conditions. Free tier monitors 1 condition weekly.
Set Up Alerts
[+]
Research Portal
Deploy this intelligence as your organization's permanent research hub — auto-updating, branded, zero hosting cost.
From $497
{<}
API Access
Integrate trial intelligence into your own tools. Full expansion engine, landscape analytics, real-time data.
View Plans
Top Recruiting Trials
20 actively recruiting studies
Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease
First Affiliated Hospital of Fujian Medical University n=24 Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian
Intervention DEVICE: Low-Intensity Focused Ultrasound Stimulation(LIFU) — This is not a traditional three-arm parallel trial but a Stage I/II dose-finding study using an adaptive design. Partici...
Eligibility Ages 18 Years – 75 Years
Contact Xin-Yuan Chen · +86 15005065282 · fychenxinyuan@fjmu.edu.cn
A Study on the Correlation Between Oral Health and Delirium in Surgical Inpatients
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine n=550 Shanghai Xinhua hospital Shanghai, Shanghai Municipality
Intervention OTHER: Oral Frailty — The exposure factor is the presence of oral frailty in patients before surgery, and oral frailty is evaluated using a sc...
Eligibility Ages 18 Years – 90 Years
Contact Aimin Shao, master · 18796080248 · 1224103064@qq.com
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
MD Stem Cells n=50 3T Radiology Coconut Creek, Florida
Eligibility Ages 18 Years
Contact Jeffrey N Weiss, MD · 954-608-7604 · jweissmd@me.com
Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
Henan Cancer Hospital n=200 Department of Bone and Soft Tissue ,Henan Cancer Hospital Zhengzhou, Henan
Intervention OTHER: Hospital Anxiety and Depression Scale — The basic information, anxiety and depression, treatment and prognosis of these patients were collected.
Contact Wang Jiaqiang, Dr · 13592413731 · wjqwtj@126.com
ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics
University of South Florida n=60 University of South Florida Tampa, Florida
Intervention BEHAVIORAL: ACT Together — ACT Together includes six self-paced, weekly web-based ACT modules and six brief phone coaching sessions delivered after...
Eligibility Ages 18 Years
Contact Areum Han, PhD · 813-396-0524 · areumhan@usf.edu
Identifying Cerebral Hemodynamic Patterns in Mood Disorders and Mild Cognitive Impairment: A Functional Near-Infrared Spectroscopy (fNIRS) Study
Mayo Clinic n=200 Mayo Clinic Rochester, Minnesota
Intervention OTHER: Observational assessment using functional near-infrared spectroscopy (fNIRS), a noninvasive, portable brain imaging tool that measures changes in brain blood flow and oxygen levels. — Functional near-infrared spectroscopy (fNIRS) transcutaneously measures changes in oxyhemoglobin in the prefrontal corte...
Eligibility Ages 18 Years
Contact Sarah M. Williams · 507-422-2972 · Williams.Sarah2@mayo.edu
Perinatal Covid-19 Infection, NO Pathway, and Minipuberty
University Hospital, Lille n=180 Hop Jeanne de Flandre Chu Lille Lille
Intervention OTHER: Inhaled NO — Newborn or young infants (\< 3 months) receiving inhaled NO as part of their treatment for severe respiratory failure
Eligibility Ages 3 Months
Contact Laurent STORME, MD,PhD · 0320445962 · laurent.storme@chru-lille.fr
The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood Pressure
Ardahan University n=50 Ardahan State Hospital Ardahan, Ardahan
Intervention OTHER: Lavender — Participants receive lavender oil inhalation three times per week for one month (total of 12 sessions) using a standardi...
Contact Derya ŞİMŞEKLİ, PhD · +905545965789 · deryasimsekli@ardahan.edu.tr
Electroacupuncture for Generalized Anxiety Disorder: Clinical Efficacy and Neuroimaging Mechanisms
Lishu Gao n=123 Affiliated Hangzhou First People's Hospital Hangzhou, Zhejiang
Intervention PROCEDURE: Electroacupuncture (EA) — Electroacupuncture (EA) is performed at acupoints including GV20 (Baihui), EX-HN1 (Sishencong), GV29 (Shenting), EX-HN16...
Eligibility Ages 18 Years – 60 Years
Contact Lishu Gao · +86 13858015836 · rodelo@sina.com
Alcohol and Sexual Communication Among Couples in the Laboratory
University of Colorado, Denver n=480 University of Colorado Anschutz Medical Campus Aurora, Colorado
Intervention OTHER: Direct Communication — Participants assigned to receive direct communication about their sexual preferences from their partner.
Eligibility Ages 21 Years – 65 Years
Contact Ruschelle M Leone, PhD · 303-724-7052 · ruschelle.leone@cuanschutz.edu
NCT06989957 PHASE1
Psilocybin and Methylenedioxymethamphetamine (MDMA) for Post-traumatic Stress Disorder (PTSD)
Johns Hopkins University n=40 Johns Hopkins Center for Psychedelic and Consciousness Research Baltimore, Maryland
Intervention DRUG: Psilocybin — Experimental Psilocybin (exact dosages not disclosed)
Eligibility Ages 21 Years
Contact Chloe Ford, MSc · 410-550-0237 · cford36@jh.edu
NCT05823532 PHASE4
Anti-Inflammatory Challenge in Schizophrenia
Emory University n=60 Grady Memorial Hospital Atlanta, Georgia
Intervention DRUG: Infliximab — Infliximab has FDA approval for the treatment of rheumatoid arthritis and inflammatory bowel syndrome. The current propo...
Eligibility Ages 18 Years – 55 Years
Contact David R Goldsmith, MD · 404-727-3735 · drgolds@emory.edu
Enhancing Generalization of Virtual Reality Exposure for Public Speaking Anxiety
Philipps University Marburg n=48 Department of Psychology, Philipps-University of Marburg Marburg, Hesse
Intervention BEHAVIORAL: VR Exposure — 6 VR speech exposure trials (3 min each; topic: "something you are proud of")
Eligibility Ages 18 Years – 70 Years
Contact Christoph Benke, Ph.D. · +49 6421 28-24091 · christoph.benke@uni-marburg.de
Longitudinal Endpoint Assessment of Disease Burden in HD
Huntington Study Group n=600 Huntington Study Group Rochester, New York
Eligibility Ages 18 Years
Contact Lauren Falanga · 800-487-7671 · info@myhdstory.org
Ejaculatory and Orgasmic Dysfunction Registry
Charitable Union for the Research and Education of Peyronie's Disease n=500 The Male Fertility and Peyronie's Clinic Orem, Utah
Eligibility Ages 18 Years
NCT05973851 PHASE3
The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Dr. Inge Winter n=418 Medical University Innsbruck Innsbruck
Intervention DRUG: Esketamine Nasal Product — See arm description
Eligibility Ages 18 Years – 65 Years
Contact Inge Winter, Dr. · +31875553227 · i.winter@umcutrecht.nl
NCT03642028 PHASE4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
VA Office of Research and Development n=190 VA Long Beach Healthcare System, Long Beach, CA Long Beach, California
Intervention DRUG: Suvorexant — Suvorexant, a dual orexin receptor antagonist, is the first in a new class of drugs with great promise of addressing ins...
Eligibility Ages 18 Years – 75 Years
Contact Sabra S Inslicht, PhD · (415) 221-4810 · sabra.inslicht@va.gov
Predictability of the Clinical Global Impression Scale (CGI) in Post Immediate in Psychotraumatic Impact
Centre Hospitalier Arras n=241 Arras General Hospital Arras
Eligibility Ages 18 Years
Contact Kathleen JACQUEZ, MSC · 03 21 21 15 99 · kathleen.jacquez@gh-artoisternois.fr
Association Between Body Composition and Pain in Spinal Cord Injury
University of Miami n=40 University of Miami Coral Gables, Florida
Intervention OTHER: Moderate Fat Meal — A liquid meal consisting of powdered protein and complex carbohydrates blended with coconut oil and peanut butter in rat...
Eligibility Ages 18 Years – 70 Years
Contact Elizabeth Felix, PhD · 305-243-4497 · efelix@med.miami.edu
Immersive Nature-Based Wellbeing Program in Older Adults With Cognitive Impairment
Consorci Sanitari de Terrassa n=230 Consorci Sanitari de Terrassa Terrassa, Barcelona
Intervention DEVICE: Immersive virtual reality program — Participants receive an immersive virtual reality intervention using nature-based environments. The program consists of ...
Eligibility Ages 65 Years
Contact Maite Garolera, PhD · +34937310007 · mgarolera@cst.cat